High-Flow Oxygen Preserve Intraoperative Body Temperature

NCT05179681 | Completed

• 1 other identifier: 201801005RINB
• Study Type: observational
• Target: 256
• Locations: 1 country
• Sites: 1

Brief Summary

Background: Hypothermia would increase the risk of bleeding, infection, cardiac complications and delay recovery. The transnasal humidified rapid-insufflation ventilatory exchange (THRIVE) could not only provide the larger oxygen preserve but also humidified high flow. However, Objectives: We wanted to investigated whether the humidified high flow of THRIVE would affect perioperative body temperature (BT). Patients and methods: We reviewed the medical records of adult patients undergoing non-intubated video-assisted thoracic surgery (NIVATS) have been retrospective reviewed. All patients have received force air warming. Multiple linear regression analysis was used to determine which factors were associated with BT loss. Expected result: In patients receiving NIVATS under force air warming, the use of THRIVE may provide more efficiently BT preserve, although the patients with oxygen mask could have acceptable BT preservation. The more BT loss is associated with the advanced age and higher BMI level. The anesthetic duration is not associated with the BT loss.

Conditions

Body Temperature Changes

Outcome Measures

Primary Outcomes (1)

• body temperature changes

  the differences of body temperature

  before operations, and arrival at postoperative care unit

Study Arms (1)

patients with non-intubated thoracic surgery

Other: Nasal High -Flow Oxygen Therapy

Interventions

Nasal High -Flow Oxygen Therapy OTHER

patients receiving transnasal humidified rapid-insufflation ventilatory exchange

patients with non-intubated thoracic surgery

Eligibility Criteria

• Age: 20 Years - 80 Years
• Sex: all
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

adult patients undergoing nonintubated video-assisted thoracic surgery (NIVATS) with either a facemask or transnasal humidified rapid-insufflation ventilatory exchange (THRIVE)

You may qualify if:

• Patients who will receive scheduled NOVATS surgery under general anesthesia Patients who met the following criteria were considered candidates for NIVATS: tumours smaller than 6 cm, peripheral lesions, no evidence of severe adhesion, no evidence of chest wall, diaphragm, or main bronchus involvement.

Sponsors & Collaborators

• National Taiwan University Hospital: lead

Study Sites (1)

Ya-Jung, Cheng

Taipei, Taiwan

Location

MeSH Terms

Conditions

Body Temperature Changes

Condition Hierarchy (Ancestors)

Signs and Symptoms; Pathological Conditions, Signs and Symptoms

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: RETROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: January 25, 2018
• First Posted: January 5, 2022
• Study Start: January 29, 2018
• Primary Completion: December 31, 2019
• Study Completion: December 31, 2019
• Last Updated: January 5, 2022

Record last verified: 2018-01

Locations

TW (1)